has primary input glucagon-like peptide-1 receptor agonist response to xenobiotic stimulus response to GLP-1 receptor agonist response to incretin mimetic A physiological or pathological response to exposure to a glucagon-like peptide-1 (GLP-1) receptor agonist. GLP-1 receptor agonists are a class of incretin-mimetic drugs that bind to and activate the GLP-1 receptor, stimulating glucose-dependent insulin secretion, suppressing glucagon release, delaying gastric emptying, and promoting satiety. This response encompasses glycemic control outcomes including HbA1c reduction, body weight changes, and other metabolic effects observed following GLP-1 receptor agonist treatment. GLP-1 receptor agonist response https://github.com/EBISPOT/efo/issues/2562 GLP-1RA response glucagon-like peptide-1 receptor agonist response AI agent